Loading clinical trials...
Loading clinical trials...
As the most common subtype of liver cancer (85% \~ 90%), HCC is highly malignant; thus, one of the crucial issues in HCC management is an effective therapy for tumors at an early stage, which is vital...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chinese PLA General Hospital
NCT07208799 · Mandible Fracture, Edema Face, and more
NCT05360069 · Postoperative Complications, Operative Time, and more
NCT06278974 · Myopia, Cost-effectiveness Analysis, and more
NCT04909606 · Long Term Corticosteroid Therapy
NCT04888936 · Costello Syndrome, Noonan Syndrome, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions